Lamictal XR 250 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F7SVE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,133
Award facts
- Contract value 100% obligated
- $13,133.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on June 25, 2026, for Lamictal XR 250 mg tablets (30-count), with a ceiling value of $13,133.22 under firm fixed-price terms.
Place of performance is Conshohocken, PA. The order has an ultimate completion date of June 26, 2026. No set-aside was applied. This is a transactional pharmaceutical delivery order typical of AmerisourceBergen's high-volume presence on DLA Troop Support Medical indefinite delivery contracts supporting military healthcare supply globally.
Quick answers
Who was awarded contract SPE2DR26F7SVE?
SPE2DR26F7SVE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 25, 2026.
How much is contract SPE2DR26F7SVE worth?
The government has obligated $13,133 on SPE2DR26F7SVE.
Is contract SPE2DR26F7SVE an order under another contract?
Yes. SPE2DR26F7SVE is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7SVE competed?
The extent of competition for SPE2DR26F7SVE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award